{"id":"https://openalex.org/W2103023541","doi":"https://doi.org/10.1345/aph.1p047","title":"Glucagon-Like Peptide-1 Analog and Insulin Combination Therapy in the Management of Adults with Type 2 Diabetes Mellitus","display_name":"Glucagon-Like Peptide-1 Analog and Insulin Combination Therapy in the Management of Adults with Type 2 Diabetes Mellitus","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-08","ids":{"openalex":"https://openalex.org/W2103023541","doi":"https://doi.org/10.1345/aph.1p047","mag":"2103023541","pmid":"https://pubmed.ncbi.nlm.nih.gov/20530705"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1p047","doi":"https://doi.org/10.1345/aph.1p047","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1p047","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103023541"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000342053","display_name":"Maria Tzefos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148244530","display_name":"Wingate University","ror":"https://ror.org/01yyxv878","country_code":"US","type":"education","lineage":["https://openalex.org/I148244530"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Tzefos","raw_affiliation_strings":["School of Pharmacy, Wingate University, Wingate, NC; Clinical Pharmacist, Cabarrus Family Medicine, Harrisburg, NC","School of Pharmacy, Wingate University, Wingate, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Wingate University, Wingate, NC; Clinical Pharmacist, Cabarrus Family Medicine, Harrisburg, NC","institution_ids":["https://openalex.org/I148244530"]},{"raw_affiliation_string":"School of Pharmacy, Wingate University, Wingate, NC","institution_ids":["https://openalex.org/I148244530"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045444582","display_name":"Jacqueline L. Olin","orcid":"https://orcid.org/0000-0003-3710-6645","observed_orcids":["https://orcid.org/0000-0003-3710-6645"]},"institutions":[{"id":"https://openalex.org/I148244530","display_name":"Wingate University","ror":"https://ror.org/01yyxv878","country_code":"US","type":"education","lineage":["https://openalex.org/I148244530"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacqueline L Olin","raw_affiliation_strings":["School of Pharmacy, Wingate University; Clinical Pharmacist, Matthews Free Medical Clinic, Matthews, NC","School of Pharmacy, Wingate University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Wingate University; Clinical Pharmacist, Matthews Free Medical Clinic, Matthews, NC","institution_ids":["https://openalex.org/I148244530"]},{"raw_affiliation_string":"School of Pharmacy, Wingate University","institution_ids":["https://openalex.org/I148244530"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I148244530"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":4.1001,"has_fulltext":false,"cited_by_count":44,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94182185,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"44","issue":"7-8","first_page":"1294","last_page":"1300"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1-analog","display_name":"glucagon-like peptide-1 analogues","score":0.9049999713897705},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9890000224113464},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9390000104904175},{"id":"https://openalex.org/keywords/insulin-combination-therapy","display_name":"insulin combination therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8169999718666077},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.828000009059906},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8510000109672546},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.8349999785423279},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9620288610458374},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9190136790275574},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6204756498336792},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.593829870223999},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.5898149013519287},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5494076013565063},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5359099507331848},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5218395590782166},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5118710398674011},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4869149923324585},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4517856538295746},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.42257004976272583},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.41128429770469666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3977506160736084},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.33630892634391785},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30782032012939453},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.14219462871551514},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1345/aph.1p047","doi":"https://doi.org/10.1345/aph.1p047","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1p047","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:20530705","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20530705","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1968426988","https://openalex.org/W1975996626","https://openalex.org/W2001097346","https://openalex.org/W2012506661","https://openalex.org/W2021513911","https://openalex.org/W2096483973","https://openalex.org/W2132257534","https://openalex.org/W2596624061"],"related_works":["https://openalex.org/W120643672","https://openalex.org/W2021718572","https://openalex.org/W2054992686","https://openalex.org/W2031488460","https://openalex.org/W2135743107","https://openalex.org/W1968426988","https://openalex.org/W2164988475","https://openalex.org/W2105269854","https://openalex.org/W2275004415","https://openalex.org/W2158030129"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,16,36,60,109,232,246,278],"efficacy":[4],"and":[5,13,48,65,71,133,141,147,160,179,194,212,214,225,264,281],"tolerability":[6],"of":[7,18,81,111,123,139,153,223,234,248,283],"combination":[8,158,183,233,285],"glucagon-like":[9,39],"peptide-1":[10,40],"(GLP-1)":[11],"analogs":[12],"insulin":[14,142,159,197,237,265],"in":[15,24,76,114,189,245,262,291],"management":[17,247],"type":[19],"2":[20],"diabetes":[21,46],"mellitus":[22],"(T2DM)":[23],"adults.":[25],"DATA":[26,53,95],"SOURCE:":[27],"A":[28],"MEDLINE":[29],"search":[30],"(1966-April":[31],"2010)":[32],"was":[33],"conducted":[34],"using":[35],"key":[37],"terms":[38],"analog,":[41],"exenatide,":[42],"incretin":[43],"mimetic,":[44],"liraglutide,":[45],"mellitus,":[47],"insulin.":[49],"STUDY":[50],"SELECTION":[51],"AND":[52],"EXTRACTION:":[54],"All":[55],"English-language":[56],"articles":[57,82],"identified":[58,85],"from":[59],"data":[61,224],"source":[62],"were":[63,74,86,267],"evaluated":[64],"reviewed":[66],"for":[67,88,93,108,166,171,257],"inclusion.":[68],"Original":[69],"research":[70],"retrospective":[72,180],"cohorts":[73],"included":[75,206],"this":[77,284],"review.":[78,94],"The":[79,136,200],"references":[80],"that":[83,105],"we":[84],"examined":[87],"any":[89],"additional":[90],"studies":[91,181,228],"appropriate":[92],"SYNTHESIS:":[96],"Exenatide":[97],"is":[98,106,143,219],"a":[99,220,242,253],"subcutaneously":[100],"administered":[101],"GLP-1":[102],"receptor":[103],"agonist":[104],"used":[107],"improvement":[110],"glycemic":[112,131],"control":[113,132],"adults":[115],"with":[116,174,236],"T2DM.":[117,175,249],"Through":[118],"actions":[119],"similar":[120],"to":[121,128,151,240,275],"those":[122],"endogenous":[124],"GLP-1,":[125],"exenatide":[126,140,161,235],"contributes":[127],"improved":[129],"postprandial":[130],"weight":[134,168,263],"loss.":[135],"concomitant":[137],"use":[138],"currently":[144],"not":[145,226],"Food":[146],"Drug":[148],"Administration-approved":[149],"due":[150],"lack":[152],"clinical":[154],"trial":[155],"data.":[156],"However,":[157],"may":[162,251],"be":[163,241,252],"advantageous,":[164],"especially":[165],"reducing":[167],"gain,":[169],"particularly":[170],"obese":[172],"patients":[173],"Several":[176],"small":[177],"prospective":[178,271],"evaluating":[182],"therapy":[184,238],"found":[185],"statistically":[186],"significant":[187],"reductions":[188,261],"hemoglobin":[190],"A(1c)":[191],"(A1C),":[192],"weight,":[193],"total":[195],"daily":[196],"dose":[198],"requirements.":[199],"most":[201],"common":[202],"adverse":[203],"effects":[204],"reported":[205],"gastrointestinal":[207],"effects,":[208],"such":[209],"as":[210,260,286,288],"nausea":[211],"vomiting,":[213],"hypoglycemia.":[215],"CONCLUSIONS:":[216],"Although":[217],"there":[218],"limited":[221],"amount":[222],"all":[227],"demonstrated":[229],"A1C":[230],"reduction,":[231],"appears":[239],"safe":[243],"option":[244],"It":[250],"promising":[254],"therapeutic":[255],"strategy":[256],"some":[258],"patients,":[259],"doses":[266],"observed.":[268],"Further":[269],"well-designed":[270],"trials":[272],"are":[273],"warranted":[274],"fully":[276],"determine":[277],"long-term":[279],"effectiveness":[280],"safety":[282],"well":[287],"its":[289],"place":[290],"therapy.":[292]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103023541","counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
